Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSA”

655 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 655 results

Not applicableStudy completedNCT01826617
What this trial is testing

Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome

Who this might be right for
Prostate CancerProstatitisBenign Prostatic Hyperplasia
St. Luke's Medical Center, Philippines 400
Large-scale testing (Phase 3)Study completedNCT02680041
What this trial is testing

18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 221
Not applicableLooking for participantsNCT06209853
What this trial is testing

Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient

Who this might be right for
Prostatic Neoplasms
Assiut University 59
Testing effectiveness (Phase 2)Study completedNCT05010577
What this trial is testing

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Who this might be right for
Chronic Pseudomonas Aeruginosa InfectionCystic Fibrosis
BiomX, Inc. 43
Large-scale testing (Phase 3)Study completedNCT00056407
What this trial is testing

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk

Who this might be right for
Neoplasms, Prostate
GlaxoSmithKline 8,231
Not applicableStudy completedNCT01473030
What this trial is testing

Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue

Who this might be right for
Benign Prostate Tissue
University of Illinois at Chicago 80
Testing effectiveness (Phase 2)Study completedNCT00148772
What this trial is testing

Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy

Who this might be right for
Prostate Cancer
Endeavor Health 29
Testing effectiveness (Phase 2)Study completedNCT02598895
What this trial is testing

Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
University of Washington 14
Testing effectiveness (Phase 2)Study completedNCT00776594
What this trial is testing

Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 102
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Testing effectiveness (Phase 2)Study completedNCT04019964
What this trial is testing

Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

Who this might be right for
Prostate CancerRecurrent Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Looking for participantsNCT04812431
What this trial is testing

Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI

Who this might be right for
Spinal Cord Injury, AcuteSpinal Cord Injury at C4 Level With Complete LesionSpinal Cord Injury at C5-C7 Level With Complete Lesion
S.Biomedics Co., Ltd. 5
Not applicableUnknownNCT03978299
What this trial is testing

Factors Associated With PSA False Negative and False Positive Results and the Impact on Patient's Health.

Who this might be right for
Prostate-Specific Antigen /Blood
Universidad Miguel Hernandez de Elche 2,527
Testing effectiveness (Phase 2)Ended earlyNCT00480857
What this trial is testing

Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 19
Not applicableStudy completedNCT01672411
What this trial is testing

Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer

Who this might be right for
Prostate Cancer
University Of Perugia 250
Early research (Phase 1)Study completedNCT00096551
What this trial is testing

A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 21
Not applicableEnded earlyNCT02031029
What this trial is testing

Character Traits and Stress in Suspected Prostate Cancer

Who this might be right for
Prostatic Diseases
Helse Stavanger HF 51
Not applicableStudy completedNCT03704389
What this trial is testing

Behavioral Economics Applications to Geriatrics Leveraging EHRs

Who this might be right for
Prostate Specific AntigenAsymptomatic BacteriuriaType 2 Diabetes Mellitus
Northwestern University 664
Large-scale testing (Phase 3)Study completedNCT01307423
What this trial is testing

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic Arthritis
Amgen 529
Testing effectiveness (Phase 2)Looking for participantsNCT04915508
What this trial is testing

Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIIC Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center 102
Load More Results